COVID-19 and Its impact on Clinical Trials If you, like most people living through this pandemic, are experiencing difficulties in keeping your trials running during the pandemic, we are here to help. We have experience in site managment, site relationships, and patient recruitment strategies that have been demonstrated to work during the pandemic. One area in particular that is worth exploring are home visits. While this seems like an easy step to take, it may have more impact than is first apparent. Everything from data quality issues to informed consent may need to be considered. We have experience with this and can assist you in evaluating whether this is an option for your trial. In addition, data handling, data analysis, and impact of COVID-19 precautions is an area in which we have experience. This is going to be an ongoing challenge for development programs, so steps taken now can assist you in a few years to ensure succesful regulatory inter
Respiratory Diseases Our expertise is in Respiratory. From first time in human studies to REMS and post marketing commitments, we have the experience to help you be successful in getting your drug to market. We can help your teams prepare for new trials, new launches, new indications, or deal with competitor threats. Of course, we have a network of people with experience in several therapeutic areas, including Rheumatology, Endocrine, Critical Care, Cardiovascular, and even Medical Device expertise.